Neither stenting nor endarterectomy provided a boost versus medical therapy alone in patients with asymptomatic stenosis.

A bundle of protocols including patient education, skin prep, and glove changes reduced infections at a large US surgical ...

The mechanism remains unclear, but GLP-1 users had less MACE, CV death, and all-cause death driven by fewer amputations.

The agency says there have been 22 injuries and no deaths associated with this potentially high-risk device issue.

Overcoming clinical inertia around starting and intensifying antihypertensive drugs is key, a researcher says.

Transparency is needed to improve equity, though it can be awkward to talk about salary, says Thomas MacGillivray.

Observational data point to the scope of opportunity that lies in GLP-1 drugs, SGLT2 inhibitors, and nonsteroidal MRAs.

The study supports “more is more” when it comes to arterial conduits until additional RCT data arrive, researcher says.

Topics spanned from GLP-1s to aorto-coronary bypass without surgery, Lp(a)’s extended reach, US dietary guidelines, and more.

NEW ORLEANS, LA—A risk model based on data from the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database (ACSD) ...

Just 7% of HFrEF patients received quadruple therapy, and even in this group, the absolute risk of events at 1 year was high.

This “long overdue” update expands the pools of patients eligible for thrombolysis and thrombectomy, and tackles pediatric ...